MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Deep learning based detection of Parkinson’s disease (PD) in Magnetic Resonance Imaging (MRI) brain scans

    M. Courtman, L. Sun, E. Ifeachor, S. Mullin (Plymouth, United Kingdom)

    Objective: To use a deep learning based framework to classify MRI brain scans as PD or control cases. Background: The Parkinson’s Progression Markers Initiative provides…
  • MDS Virtual Congress 2021

    Tractography Analysis of the Pedunculopontine Nucleus Correlates with Gait Impairment in Parkinson’s Disease

    S. Joza, R. Camicioli, F. Ba (Edmonton, Canada)

    Objective: Our objective was to correlate pedunculopontine nucleus (PPN) connectivity with quantitative gait metrics in Parkinson’s disease (PD) using diffusion tensor imaging (DTI). Background: Gait…
  • MDS Virtual Congress 2021

    Resting state functional connectivity networks related to MDS-UPDRS motor outcomes in Parkinson’s Disease

    A. Ragothaman, M. Mancini, J. Nutt, D. Fair, O. Miranda-Dominguez, F. Horak (Portland, USA)

    Objective: Investigate the functional connectivity network pairs associated with the motor symptoms in people with Parkinson’s disease (pwPD). Background: PD is a neurodegenerative disorder primarily…
  • MDS Virtual Congress 2021

    The modification of iron accumulation in nigrosome by levodopa treatment in early Parkinson’s disease

    MD. Wang, HC. Wang, HX. Wang, J. Wang, SJ. Lu, RL. Ge, JB. Chen (Binzhou, China)

    Objective: The study was to investigate the alteration of iron accumulation in nigrosome for the early treatment of dopamine loss in PD. Background: Iron accumulation…
  • MDS Virtual Congress 2021

    The aperiodic component of cortical Local Field Potentials is affected in Parkinson’s Disease and Essential Tremor.

    A. Bush, J. Zou, W. Lipski, RM. Richardson (Boston, USA)

    Objective: Characterize the pathophysiology of Parkinson’s Disease (PD) and Essential Tremor (ET) in terms of cortical and subcortical aperiodic neural activity. Background: Classical analysis of…
  • MDS Virtual Congress 2021

    COVID-19 PANDEMIC: SYMPTOMS PERCEPTIONS FROM PARKINSON’S DISEASE PATIENTS

    A. Braga, L. Brito, F. Rolim, P. Andrade, A. Marinho, A. Moura, H. Freitas, I. Nobrega, I. Dantas, F. Carvalho (Fortaleza, Brazil)

    Objective: Our study aimed to evaluate PD patients’ perception regarding clinical aspects, physical activity and restricted access to medication during the pandemic. Background: Several countries…
  • MDS Virtual Congress 2021

    Leg muscle contractions compensate for declining cardiac baroreflex in PD Patients

    A. Huether, R. Fadil, R. Brunnemer, T. Harlow, A. Stutz, S. Matcha, A. Hanson, A. Blaber, K. Tavakolian, J-S. Lou (Fargo, USA)

    Objective: To investigate if impairments in muscle contraction affects blood pressure (BP) regulation in PD. Background: Orthostatic hypotension (OH) contributes to unexpected falls in PD.…
  • MDS Virtual Congress 2021

    The effect of exercise on pain in Parkinson’s disease: a systematic review

    V. Nguy, F. Pourkazemi, L. Hassett, C. Canning, J. Elliott, N. Allen (Sydney, Australia)

    Objective: To perform a systematic review assessing the effects of exercise on pain in people with Parkinson’s disease (PD) (PROSPERO registration CRD42019129154). Background: Chronic pain…
  • MDS Virtual Congress 2021

    THE SEVERITY OF MOTOR SYMPTOMS IS A RISK FACTOR FOR SEBORRHEIC DERMATITIS IN PARKINSON’S DISEASE PATIENTS

    I. Kuric, T. Gilman Kuric, Z. Popovic, J. Kragujevic, T. Mirosevic Zubonja, I. Rajkovaca, S. Matosa, S. Tomic ()

    Objective: The aim was to determine correlation and difference according to severity of SD with motor and nonmotor symptoms, age, gender and levodopa equivalent daily…
  • MDS Virtual Congress 2021

    Sphingosine-1-phosphate, motor severity and progression in Parkinson’s disease (MARK-PD)

    C. Choe, C. Englisch, L. Niemann, S. Lezius, M. von Lucadou, K. Marmann, R. Böger, S. Peine, G. Daum, C. Gerloff, E. Schwedhelm (Hamburg, Germany)

    Objective: We assessed the association of serum sphingosine-1-phosphate (S1P) levels with motor and cognitive symptoms in patients with Parkinson’s disease (PD). Background: Treatment with sphingosine-1-phosphate…
  • « Previous Page
  • 1
  • …
  • 297
  • 298
  • 299
  • 300
  • 301
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley